UCB and Biogen’s lupus candidate showed strong Phase 3 results, including fatigue improvement and higher remission versus standard care.
Biogen, UCB Take A Leap In Lupus With Promising Phase 3 Results
Where Today's News Shapes Tomorrow
July 11, 2025
Headlines